Developments

Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity

Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity Lifeblood and Anticoagulation Europe are both very concerned that the NICE recommendations that there should be equal access to VKAs (warfarin) and NOACs in the NICE approved indications are not being implemented. The NHS constitution states that patients should not be denied access to NICE approved drugs.

Read more »

National Anticoagulation Initiative

The National Anticoagulation Initiative aims to decrease strokes in at-risk patients with Atrial Fibrillation (AF), by promoting appropriate, safe and locally available oral anticoagulation. The scalable National AC initiative, which is lead by Professor Sir Muir Gray (of Better Value Healthcare), has been working with influential thought leaders since 2012 to discuss treatment, best practice and benchmarking, with the aim of taking this forward into more populations nationwide.

Read more »

Michael Rawlins: playing fair on treatments

Trusts that do not allow drugs approved by NICE to be prescribed are breaking the law

Read more »

Strike out Stroke

Urgent coordinated action is needed to avoid the thousands of preventable strokes that leave many atrial fibrillation (AF) patients mentally and physically disabled or dead, every year.

Read more »

Patients capable of self-monitoring their anticoagulation therapy

Patients capable of self-monitoring their warfarin therapy could benefit from a one-third reduction in death from all causes, according to a meta-analysis in this week's issue of The Lancet.

Read more »

Dabigatran has received a licence for the prevention of deep vein thrombosis and pulmonary embolism after hip and knee surgery

Study shows dabigatran etexilate, a new oral anticoagulant, is effective and safe in preventing thromboembolic disease after orthopaedic surgery.

Read more »

Expert pharmacists get the go ahead

Pharmacists with Special Interests (PhwSIs) are to offer care and advice about diabetes, and long-term conditions on patients doorsteps.

Read more »

New guidelines for atrial fibrillation

New guidelines aim to increase the identification and treatment of atrial fibrillation (AF) a 'hidden disease' that is the commonest sustained cardiac rhythm disorder.

Read more »

Front Line in Stroke Prevention - Report

The Front Line Report was commissioned to look at the current status of anticoagulation treatment in the UK and to identify key issues that anticoagulation clinics and the patients who attend these clinics face.

Read more »

Venous thromboembolism CMO press release

Every hospital patient should have their own risk assessment for VTE that will improve patient safety and help save thousands of lives each year, says an expert working group whose report was launched by the Chief Medical Officer (CMO) today.

Read more »

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP. Registered Charity: 1090250
Privacy | Terms & Conditions © Anticoagulation Europe 2011
Web design by Bright White Space